Grantham Mayo Van Otterloo & Co. LLC Purchases Shares of 4,800 Waters Corporation $WAT

Grantham Mayo Van Otterloo & Co. LLC acquired a new position in shares of Waters Corporation (NYSE:WAT) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 4,800 shares of the medical instruments supplier’s stock, valued at approximately $1,439,000.

Other large investors also recently made changes to their positions in the company. Brighton Jones LLC boosted its position in Waters by 112.9% during the 4th quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock worth $471,000 after purchasing an additional 673 shares during the period. Integrated Wealth Concepts LLC raised its position in Waters by 2.9% in the first quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock valued at $386,000 after purchasing an additional 30 shares during the period. Goldman Sachs Group Inc. lifted its stake in shares of Waters by 3.6% during the first quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock worth $73,733,000 after purchasing an additional 6,976 shares in the last quarter. Empowered Funds LLC lifted its stake in shares of Waters by 16.6% during the first quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock worth $415,000 after purchasing an additional 160 shares in the last quarter. Finally, Sivia Capital Partners LLC purchased a new stake in shares of Waters in the second quarter worth about $232,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on WAT. Evercore began coverage on Waters in a report on Tuesday, February 10th. They set a “hold” rating and a $360.00 target price on the stock. UBS Group decreased their price target on Waters from $395.00 to $370.00 and set a “neutral” rating for the company in a report on Tuesday, February 10th. HSBC assumed coverage on shares of Waters in a research note on Tuesday, January 27th. They set a “buy” rating and a $460.00 price objective on the stock. Morgan Stanley decreased their target price on shares of Waters from $423.00 to $350.00 and set an “equal weight” rating for the company in a research note on Sunday, February 22nd. Finally, Robert W. Baird set a $363.00 price target on shares of Waters in a research note on Tuesday, February 10th. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $393.84.

Waters Stock Performance

Shares of WAT opened at $299.79 on Wednesday. The firm has a market cap of $29.41 billion, a price-to-earnings ratio of 27.84, a PEG ratio of 2.11 and a beta of 1.20. The company has a quick ratio of 1.27, a current ratio of 1.73 and a debt-to-equity ratio of 0.37. The business’s 50 day moving average is $358.17 and its two-hundred day moving average is $351.75. Waters Corporation has a 52-week low of $275.05 and a 52-week high of $414.15.

Waters (NYSE:WAT) last released its quarterly earnings results on Monday, February 9th. The medical instruments supplier reported $4.53 earnings per share for the quarter, topping analysts’ consensus estimates of $4.50 by $0.03. The business had revenue of $932.36 million during the quarter, compared to the consensus estimate of $928.17 million. Waters had a net margin of 20.30% and a return on equity of 34.79%. The business’s quarterly revenue was up 6.9% compared to the same quarter last year. During the same quarter last year, the company earned $4.10 earnings per share. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. Analysts forecast that Waters Corporation will post 12.86 EPS for the current fiscal year.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.